Longevity Health Holdings, Inc. Selling and Marketing Expense
Longevity Health Holdings, Inc. (XAGE) reported Selling and Marketing Expense of $191.44 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-14
- Longevity Health Holdings, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $191.44K, a 44.59% decline year-over-year.
- Longevity Health Holdings, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $270.64K, a 3.53% decline year-over-year.
- Longevity Health Holdings, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $335.69K, a 476.64% increase year-over-year.
- Longevity Health Holdings, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $358.54K, a 198.62% increase year-over-year.
- Longevity Health Holdings, Inc. selling and marketing expense for fiscal 2025 was $1.42M, a 651.65% increase from fiscal 2024.
- Longevity Health Holdings, Inc. selling and marketing expense for fiscal 2024 was $189.32K.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 5 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $191.44K 10-Q · filed 2026-08-14 | $462.07K 10-Q · filed 2026-08-14 | $797.77K derived: sum of 3 quarters · filed 2026-08-14 | $1.16M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $270.64K 10-Q · filed 2026-05-15 | $606.33K derived: sum of 2 quarters · filed 2026-05-15 | $964.87K derived: sum of 3 quarters · filed 2026-05-15 | $1.31M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $335.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $694.23K derived: sum of 2 quarters · filed 2026-03-31 | $1.04M derived: sum of 3 quarters · filed 2026-08-14 | $1.42M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $358.54K 10-Q · filed 2025-11-14 | $704.04K derived: sum of 2 quarters · filed 2026-08-14 | $1.09M 10-Q · filed 2025-11-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $345.50K 10-Q · filed 2026-08-14 | $626.05K 10-Q · filed 2026-08-14 | $684.27K derived: sum of 3 quarters · filed 2026-08-14 | $804.33K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $280.55K 10-Q · filed 2026-05-15 | $338.76K derived: sum of 2 quarters · filed 2026-05-15 | $458.83K derived: sum of 3 quarters · filed 2026-05-15 | $469.87K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $58.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $178.28K derived: sum of 2 quarters · filed 2026-03-31 | $189.32K derived: sum of 3 quarters · filed 2026-03-31 | $189.32K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $120.06K 10-Q · filed 2025-11-14 | $131.11K derived: sum of 2 quarters · filed 2025-11-14 | $131.11K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | $11.04K 10-Q · filed 2025-08-14 | $11.04K 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $100.00K 10-Q · filed 2024-05-15 | |||||
| 2023-12-31 | $6.83M 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $3.07M 10-Q · filed 2023-11-15 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $3.07M 10-Q · filed 2023-11-15 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | |||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-15 | $0.00 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |